Q4 2015 13F Holders as of 31 Dec 2015
-
Type / Class
-
Equity / Common Shares, no par value
-
Shares outstanding
-
130,702,820
-
Number of holders
-
14
-
Total 13F shares, excl. options
-
6,732,938
-
Shares change
-
-377,335
-
Total reported value, excl. options
-
$16,753,741
-
Value change
-
-$1,105,844
-
Number of buys
-
7
-
Number of sells
-
3
-
Price
-
$2.47
Institutional Holders of Aurinia Pharmaceuticals Inc. - Common Shares, no par value (AUPH) as of Q4 2015
As of 31 Dec 2015 Aurinia Pharmaceuticals Inc. - Common Shares, no par value (AUPH) had 14 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 6,732,938 shares of stock of the company.
Largest 10 holders included NEA Management Company, LLC, GREAT POINT PARTNERS LLC, BAKER BROS. ADVISORS LP, EverPoint Asset Management, LLC, MILLENNIUM MANAGEMENT LLC, Lombard Odier Asset Management (USA) Corp, RENAISSANCE TECHNOLOGIES LLC, UBS Group AG, Redmile Group, LLC, and ROYAL BANK OF CANADA.
This table shows 14 institutional shareholders of the security as of 31 Dec 2015.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.